SEI Trust Company’s Acadia Pharmaceuticals ACAD Stock Holding History

SEI Trust Company’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$883K	Sell	35,656 -6,430	-15%	-$150K	0.01%	942
2014 Q2	$951K	Sell	42,086 -2,350	-5%	-$49.1K	0.01%	919
2014 Q1	$1.08M	Sell	44,436 -6,519	-13%	-$165K	0.01%	884
2013 Q4	$1.27M	Buy	50,955 +1,335	+3%	+$31.5K	0.01%	860
2013 Q3	$1.36M	Sell	49,620 -830	-2%	-$17.4K	0.02%	770
2013 Q2	$916K	Buy	+50,450	New	+$695K	0.01%	760

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SEI Trust Company's ACAD Position: Q3 2014 in Review

SEI Trust Company reduced its Acadia Pharmaceuticals (ACAD) stake by 15% in Q3 2014, selling an estimated $150K and leaving 35,656 shares worth $883K. The position accounts for 0.01% of the portfolio, ranked #942.

SEI Trust Company first reported a position in ACAD in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.36M in Q3 2013. 162 funds tracked by Wall St. Rank hold ACAD as of Q3 2014.

SEI Trust Company held 35,656 shares of Acadia Pharmaceuticals worth $883K as of Q3 2014.
SEI Trust Company sold 6,430 Acadia Pharmaceuticals shares in Q3 2014, an estimated $150K.
Acadia Pharmaceuticals made up 0.01% of SEI Trust Company's portfolio in Q3 2014, its #942 holding.
SEI Trust Company first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
SEI Trust Company's Acadia Pharmaceuticals position peaked at $1.36M in Q3 2013.
162 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.